Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Total Debt (2019 - 2025)

Volitionrx (VNRX) has disclosed Total Debt for 8 consecutive years, with $5.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Debt rose 22.53% year-over-year to $5.9 million, compared with a TTM value of $5.9 million through Sep 2025, up 22.53%, and an annual FY2024 reading of $4.0 million, down 18.19% over the prior year.
  • Total Debt was $5.9 million for Q3 2025 at Volitionrx, down from $6.8 million in the prior quarter.
  • Across five years, Total Debt topped out at $6.8 million in Q2 2025 and bottomed at $2.8 million in Q3 2021.
  • Average Total Debt over 5 years is $4.2 million, with a median of $3.8 million recorded in 2022.
  • Peak annual rise in Total Debt hit 43.61% in 2024, while the deepest fall reached 18.19% in 2024.
  • Year by year, Total Debt stood at $3.1 million in 2021, then grew by 25.33% to $3.8 million in 2022, then grew by 25.64% to $4.8 million in 2023, then decreased by 18.19% to $4.0 million in 2024, then soared by 48.88% to $5.9 million in 2025.
  • Business Quant data shows Total Debt for VNRX at $5.9 million in Q3 2025, $6.8 million in Q2 2025, and $6.4 million in Q1 2025.